ClinicalTrials.gg
CompletedNCT05999045Updated Jan 11, 2024

Turkish Version of Evaluation of the Ability to Sing Easily (EASE-TR)

An observational study in Voice Fatigue, sponsored by Hacettepe University. Completed at 1 site in Turkey. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-01-11.

Sponsored by Hacettepe University · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
100
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The aim of the study is to translate and culturally adapt the Turkish version of the EASE (EASE-TR) scale and investigate its validity and reliability.

Read the detailed description

The study consists of two phases. In the first phase of the study, the scale will be translated and culturally adapted into Turkish. The second phase involves assessing participants and validating the translated scale. In this phase, participants will complete the EASE-TR and the severity part of the Vocal Tract Discomfort Scale (VTDS) before and after a 1-hour performance. One hundred choir member between the ages of 18 and 65 will be included in the study.

Both construct and criterion validity procedures will be used.Within the scope of construct validity, the "Known Groups Validity" method will be used based on variables such as experience duration, vocal training status, and the presence or absence of current vocal complaints. A comparison of pre- and post-performance EASE-TR scores will be conducted. Regarding criterion validity, the correlation between EASE scores and the severity part of the VTDS will be examined. For reliability, Cronbach's alpha and test-retest reliability will be calculated. The questionnaire will be administered a second time to 30 participants after 14 days in order to measure test-retest reliability.

02

Conditions studied

  • Voice Fatigue

Browse trials for

Keywords

  • Singing voice
  • Professional voice users
03

In context

Voice Disorders

77 studies on the registry are indexed under Voice Disorders; 17 are open to participants now.

This study's enrollment of 100 is close to the median of 100 across 23 observational studies indexed under Voice Disorders.

Browse Voice Disorders studies →

Lead sponsor

Hacettepe University is the lead sponsor of 1,007 studies on the registry; 214 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Participants who sings in a professional or unprofessional choir

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Having Turkish as mother tongue
  • Singing in choir at least 6 months
  • Performing at least for an hour

Exclusion criteria

Exclusion Criteria:

  • Having previously received voice therapy or undergone voice surgery
  • Having a systematic/or neurological disorder that may affect voice quality
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
100 participants (actual)
Patient registry
No

Groups and cohorts

  • choir member

    a person who sings in a choir

    Other: Singing activity

Interventions

  • OtherSinging activity

    The singing activity will involve a 1-hour performance, rehearsal, or lesson.

06

What researchers measure

Primary outcomes

  1. Change in Evaluation of the Ability to Sing Easily (EASE) Turkish Version score

    Turkish Version of Evaluation of the Ability to Sing Easily score: scoring ranges from 22 to 88 with higher score meaning worse outcome

    Time frame: 1-hour singing activity

Secondary outcomes

  1. Vocal Tract Discomfort Scale (VTDS)

    The severity part of the Vocal Tract Discomfort Scale (VTDS): scoring ranges from 0 to 48 with higher score meaning worse outcome

    Time frame: 1-hour singing activity

07

Study locations

1 site
  • Hacettepe University
    Ankara, 06100, Turkey
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 11, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05999045
Responsible party
MERVE OGULMUS UYSAL (Principal Investigator, Hacettepe University) — Principal investigator
First posted
Aug 21, 2023
Start date
Aug 10, 2023
Primary completion
Oct 1, 2023
Completion
Oct 1, 2023
Last update
Jan 11, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion